Skip to content
MedsAcross

Brand family

Lybalvi

United States
Presentations
4
Markets
1

Lybalvi is a brand of Olanzapine and Samidorphan l-malate marketed by Alkermes, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Olanzapine and Samidorphan l-malate
Brand owner
Alkermes
Registered in
United States
Strengths and forms
10 mg/10 mg tablet, 15 mg/10 mg tablet, 20 mg/10 mg tablet, 5 mg/10 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Lybalvi 10 mg/10 mg tabletOralAlkermesUS FDAAvailable on request
Lybalvi 15 mg/10 mg tabletOralAlkermesUS FDAAvailable on request
Lybalvi 20 mg/10 mg tabletOralAlkermesUS FDAAvailable on request
Lybalvi 5 mg/10 mg tabletOralAlkermesUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Lybalvi

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.